"As required by the bipartisan FDA Food Safety Modernization Act (FSMA), the U.S. Food and Drug Administration today proposed a rule that would require the largest food businesses in the United States and abroad to take steps to prevent facilities"...
- Patient Information:
Details with Side Effects
Vitamin A injection is effective for the treatment of vitamin A deficiency.
The parenteral administration is indicated when the oral administration is not feasible as in anorexia, nausea, vomiting, pre- and postoperative conditions, or it is not available as in the "Malabsorption Syndrome" with accompanying steatorrhea.
Pediatric Use: Vitamin A treatment for deficiency states has been recognized as an especially effective and important therapy in the pediatric population.
Vitamin A supplementation for deficiency states in this population has been addressed by the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition, by the American Society for Parenteral and Enteral Nutrition, and by the World Health Organization.
DOSAGE AND ADMINISTRATION
For intramuscular use.
100,000 Units daily for three days followed by 50,000 daily for two weeks.
II. Pediatric patients 1 to 8 years old
17,500 to 35,000 Units daily for 10 days.
7,500 to 15,000 Units daily for 10 days.
Follow-up therapy with an oral therapeutic multivitamin preparation, containing 10,000 to 20,000 Units vitamin A for adults and for pediatric patients over 8 years old, and 5,000 to 10,000 Units for infants and other pediatric patients under 8 years old, is recommended daily for two months. Low birth-weight infants may require additional vitamin A though the exact dosing in these pediatric patients has not been established. In malabsorption, the parenteral route must be used for an equivalent preparation.
Poor dietary habits should be corrected and an abundant and well-balanced dietary intake should be prescribed.
AQUASOL A® Parenteral (water-miscible vitamin A Palmitate) is available as: NDC 61703-418-07; 50,000 USP Units (15 mg retinol/mL); 2 mL single-dose vial, box of 10.
Store at 2-8°C (36-46°F). Do not freeze.
Manufactured for: Mayne Pharma (USA) Inc. Paramus, NJ 07652. Manufactured by: AstraZeneca LP, Westborough, MA01581. FDA Rev date: 06/09/00
Last reviewed on RxList: 8/13/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Aquasol A Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight Loss Wisdom
Get tips, recipes and inspiration.